Kirkland & Ellis March 8, 2023

Healthcare Private Equity Transactions in 2023

The healthcare sector is anticipated to remain an attractive investment for private equity in 2023, especially in high-demand categories such as behavioral health, health IT, and specialty physician platforms such as orthopedics. We also anticipate a strong investment market across the life sciences, including transactions involving specific drug compounds and patented molecules, as well as ancillary businesses such as clinical research organizations, pharmaceutical outsourcing and consulting services. These types of healthcare investments are viewed as relatively downward resilient, with recessionary factors countered by the base high-demand volume. We also anticipate liability management to remain active amidst a fairly tight credit market.

Continued Government Focus on Private Equity Investment in Healthcare

Federal and state regulators...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Mergers & Acquisitions / JV, Survey / Study, Trends
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Pelago Defies Digital Health Funding Drought, Raises $58M
Digital health venture capital deals stagnate
Boundless Bio’s ‘BOLD’ IPO Reels In $100M for a New Kind of Cancer Drug
Is AI’s next big leap understanding emotion? $50M for Hume says yes

Share This Article